Technologies related to Endocrine

Device for Selectively Removing Cells from a Biological Sample
Ref: E-045-2014/0 | Updated: Nov 30, 2015
Rabbit Antisera to Various Matrix, Matricellular, and Other Secreted Proteins
Ref: E-135-2008/0 | Updated: Aug 11, 2015
A Novel Adeno-Associated Virus for Gene Therapy
Ref: E-175-2015/0 | Updated: Nov 1, 2017
Modified AAV5 Vectors for Enhanced Transduction and Reduced Antibody Neutralization
Ref: E-097-2015/0 | Updated: Nov 1, 2017
Treatment of Chronic Kidney Disease with Synthetic Amphipathic Peptides
Ref: E-743-2013/0 | Updated: Jun 2, 2014
Monoclonal Antibody Fragments for Targeting Therapeutics to Growth Plate Cartilage
Ref: E-003-2014/0 | Updated: Jun 29, 2017
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013/0 | Updated: Mar 18, 2014
Methods of Retaining Methylation Pattern Information in Globally Amplified DNA
Ref: E-243-2013/0 | Updated: Feb 6, 2014
Automated Microscopic Image Acquisition, Compositing and Display Software Developed for Applied Microscopy/Cytology Training and Analysis
Ref: E-228-2013/0 | Updated: Feb 6, 2014
Therapeutic, Bifunctional Janus Microparticles with Spatially Segregated Surface Proteins and Methods of Production
Ref: E-457-2013/1 | Updated: Jan 28, 2014
Photoinduced Electron Transfer Fluorescent Primer for Nucleic Acid Amplification
Ref: E-292-2013/0 | Updated: Feb 17, 2016
Fluorescent Primer(s) Creation for Nucleic Acid Detection and Amplification
Ref: E-252-2013/0 | Updated: Jan 27, 2014
Use of Detector Response Curves to Optimize Settings for Mass Spectrometry
Ref: E-157-2013/0 | Updated: Jan 20, 2014
Novel Regulatory B cells for Treatment of Cancer and Autoimmune Disease
Ref: E-101-2010/0 | Updated: Sep 21, 2015
Coacervate Microparticles Useful for the Sustained Release Administration of Therapeutic Agents
Ref: E-116-2004/0 | Updated: Jun 29, 2017
PDE11A Mutations in Adrenal Disease
Ref: E-027-2006/0 | Updated: Dec 8, 2017
Subscribe to Technologies related to Endocrine